Both in Medical Labs
CareDx vs GRAIL
Over the past year CDNA returned +482.7% and GRAL returned +56.0%; their daily moves had a correlation of 0.30.
CDNA +482.7% GRAL +56.0%Growth of $1, one year, split-adjusted
| Metric | CDNA | GRAL |
|---|---|---|
| Price | $87.41 | $143.43 |
| Market cap | $4.59B | $6.41B |
| Today | +22.22% | −9.75% |
| 1 month | +32.0% | +8.2% |
| 6 months | +306.6% | +165.3% |
| Year to date | +364.0% | +67.6% |
| 1 year | +512.1% | — |
| Revenue growth (YoY) | +39.3% | +25.7% |
| Gross margin | 71.1% | −28.1% |
| Net margin | 13.8% | −246.7% |
| P/E (TTM) | 35.7× | — |
| Price / sales | 9.2× | 38.8× |
| Net cash | $250.5M | $861.6M |
| Dividend yield | — | — |
| Volatility (60d) | 61.7% | 103.3% |
| Short % of float | 13.4% | 19.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).